This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Lg Chem-Investment Ltd., Lg Life Sciences, Limited. Active years: 2004-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2009
Title: Tae-Kyo Park: Innovator in Caspase Inhibition
Introduction
Tae-Kyo Park is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of caspase inhibitors. With a total of 2 patents to his name, his work focuses on innovative solutions for preventing inflammation and apoptosis.
Latest Patents
Tae-Kyo Park's latest patents include two significant inventions related to isoxazoline derivatives. The first patent, titled "Caspase inhibitors containing isoxazoline ring," describes an isoxazoline derivative that acts as an inhibitor against various caspases. This invention also outlines a process for preparing the derivative and a therapeutic composition aimed at preventing inflammation and apoptosis. The second patent, "Isoxazoline derivative and a process for the preparation thereof," provides details on an isoxazoline derivative of formula (I) and its pharmaceutically acceptable salts, esters, and stereochemically isomeric forms. This invention emphasizes the derivative's use in inhibiting caspase activity and its potential applications in treating diseases associated with abnormal cell death, such as dementia, cerebral stroke, AIDS, diabetes, gastric ulcers, hepatic injury from hepatitis, sepsis, organ transplantation rejection, and anti-inflammation.
Career Highlights
Throughout his career, Tae-Kyo Park has worked with prominent companies in the pharmaceutical industry, including LG Chem Investment Ltd. and LG Life Sciences, Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Tae-Kyo Park has collaborated with several professionals in his field, including Mi-Jeong Park and Hye-Kyung Chang. These collaborations have likely enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Tae-Kyo Park is a distinguished inventor whose work in caspase inhibition has the potential to impact various medical conditions significantly. His innovative patents and collaborations reflect his commitment to advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile